Kennedy Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Buy
112,908
+51,845
+85% +$5.32M 0.23% 161
2025
Q4
$6.48M Sell
61,063
-9,474
-13% -$1.1M 0.14% 244
2025
Q3
$8.96M Sell
70,537
-40,991
-37% -$4.88M 0.2% 182
2025
Q2
$13.7M Sell
111,528
-48,283
-30% -$5.51M 0.33% 85
2025
Q1
$16.2M Buy
159,811
+64,538
+68% +$6.3M 0.39% 66
2024
Q4
$8.8M Sell
95,273
-1,771
-2% -$174K 0.2% 161
2024
Q3
$9.38M Sell
97,044
-5,581
-5% -$502K 0.21% 151
2024
Q2
$8.8M Buy
102,625
+2,905
+3% +$244K 0.19% 180
2024
Q1
$8.23M Buy
99,720
+16,318
+20% +$1.2M 0.17% 214
2023
Q4
$5.56M Buy
83,402
+2,173
+3% +$141K 0.12% 286
2023
Q3
$5.46M Buy
81,229
+4,609
+6% +$317K 0.13% 267
2023
Q2
$5.19M Buy
76,620
+52,620
+219% +$3.3M 0.12% 289
2023
Q1
$1.3M Buy
24,000
+4,509
+23% +$262K 0.04% 453
2022
Q4
$1.17M Buy
19,491
+149
+0.8% +$8.1K 0.03% 474
2022
Q3
$875K Sell
19,342
-5,032
-21% -$252K 0.03% 497
2022
Q2
$1.09M Sell
24,374
-614
-2% -$31.5K 0.03% 464
2022
Q1
$1.41M Buy
24,988
+4,269
+21% +$223K 0.03% 465
2021
Q4
$1.08M Sell
20,719
-1,707
-8% -$88.1K 0.02% 507
2021
Q3
$1.34M Buy
22,426
+7,619
+51% +$479K 0.03% 499
2021
Q2
$919K Buy
14,807
+3,460
+30% +$231K 0.02% 527
2021
Q1
$739K Buy
11,347
+6,651
+142% +$434K 0.01% 568
2020
Q4
$309K Buy
+4,696
New +$276K 0.01% 626
2017
Q1
Sell
-260,719
Closed -$8.55M 732
2016
Q4
$8.55M Sell
260,719
-23,846
-8% -$774K 0.15% 227
2016
Q3
$9.18M Sell
284,565
-8,078
-3% -$262K 0.18% 197
2016
Q2
$9.04M Sell
292,643
-281,576
-49% -$8.81M 0.18% 186
2016
Q1
$17.2M Sell
574,219
-2,990
-0.5% -$82.6K 0.35% 56
2015
Q4
$16M Sell
577,209
-203,310
-26% -$5.78M 0.32% 67
2015
Q3
$23.8M Buy
780,519
+1,124
+0.1% +$39.1K 0.49% 26
2015
Q2
$28.6M Buy
779,395
+370,546
+91% +$13.2M 0.51% 20
2015
Q1
$14.4M Sell
408,849
-101,382
-20% -$3.47M 0.25% 111
2014
Q4
$15.6M Buy
510,231
+126,642
+33% +$3.95M 0.29% 79
2014
Q3
$11.3M Sell
383,589
-72,893
-16% -$2.22M 0.22% 137
2014
Q2
$13M Sell
456,482
-103,522
-18% -$2.89M 0.24% 129
2014
Q1
$16M Sell
560,004
-161,752
-22% -$4.21M 0.3% 80
2013
Q4
$19.1M Buy
721,756
+5,018
+0.7% +$140K 0.35% 57
2013
Q3
$19.7M Buy
716,738
+9,894
+1% +$254K 0.38% 46
2013
Q2
$16.2M Buy
+706,844
New +$16M 0.33% 64

Other funds holding EHC

Kennedy Capital Management's EHC Position: Q1 2026 in Review

Kennedy Capital Management increased its Encompass Health (EHC) stake by 85% in Q1 2026, buying an estimated $5.32M and bringing the position to 112,908 shares worth $10.9M. The position accounts for 0.23% of the portfolio, ranked #161.

Kennedy Capital Management first reported a position in EHC in Q2 2013 and has held it in 37 quarters since. The position peaked at $28.6M in Q2 2015. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Kennedy Capital Management held 112,908 shares of Encompass Health worth $10.9M as of Q1 2026.
  • Kennedy Capital Management bought 51,845 Encompass Health shares in Q1 2026, an estimated $5.32M.
  • Encompass Health made up 0.23% of Kennedy Capital Management's portfolio in Q1 2026, its #161 holding.
  • Kennedy Capital Management first reported a position in Encompass Health in Q2 2013 and has held it in 37 quarters since.
  • Kennedy Capital Management's Encompass Health position peaked at $28.6M in Q2 2015.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.